
Aurinia Showcases Real-World Data on LUPKYNIS® for Lupus Nephritis at ASN Kidney Week 2024
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) announced the acceptance of six abstracts, including five poster presentations, at the American Society of Nephrology (ASN) Kidney Week 2024, happening in San Diego, CA…











